Symbols / MASI Stock $178.49 -0.10% Masimo Corporation

Healthcare • Medical Devices • United States • NMS
MASI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Ms. Catherine M. Szyman
Exch · Country NMS · United States
Market Cap 9.35B
Enterprise Value 9.73B
Income 207.70M
Sales 1.53B
FCF (ttm) 316.41M
Book/sh 13.84
Cash/sh 2.92
Employees 2,200
Insider 10d —
IPO Aug 08, 2007
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 46.72
Forward P/E 27.04
PEG 4.83
P/S 6.12
P/B 12.89
P/C —
EV/EBITDA 28.18
EV/Sales 6.37
Quick Ratio 1.29
Current Ratio 2.49
Debt/Eq 77.55
LT Debt/Eq —
EPS (ttm) 3.82
EPS next Y 6.60
EPS Growth —
Revenue Growth 12.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-27
ROA 8.86%
ROE 23.43%
ROIC —
Gross Margin 61.80%
Oper. Margin 18.52%
Profit Margin -9.92%
Shs Outstand 52.36M
Shs Float 47.45M
Insider Own 5.00%
Instit Own 108.26%
Short Float 8.01%
Short Ratio 2.73
Short Interest 3.82M
52W High 179.00
vs 52W High -0.29%
52W Low 125.94
vs 52W Low 41.72%
Beta 1.20
Impl. Vol. 3.95%
Rel Volume 0.31
Avg Volume 1.63M
Volume 510.54K
Target (mean) $180.00
Tgt Median $180.00
Tgt Low $180.00
Tgt High $180.00
# Analysts 4
Recom None
Prev Close $178.66
Price $178.49
Change -0.10%
About

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$180.00
Mean price target
2. Current target
$178.49
Latest analyst target
3. DCF / Fair value
$108.77
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$178.49
Low
$180.00
High
$180.00
Mean
$180.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 down Raymond James Outperform → Market Perform —
2026-02-18 down Wells Fargo Overweight → Equal-Weight $180
2026-02-18 down BTIG Buy → Neutral —
2025-12-04 main BTIG Buy → Buy $200
2025-11-24 reit BTIG Buy → Buy $198
2025-11-17 init B of A Securities — → Neutral $162
2025-11-05 main Wells Fargo Overweight → Overweight $187
2025-11-05 reit BTIG Buy → Buy $198
2025-09-11 reit BTIG Buy → Buy $198
2025-08-06 main Piper Sandler Overweight → Overweight $210
2025-05-07 main Raymond James Outperform → Outperform $185
2025-05-07 reit Piper Sandler Overweight → Overweight $200
2025-05-07 main Wells Fargo Overweight → Overweight $190
2025-04-10 reit Needham Hold → Hold —
2025-02-26 main Piper Sandler Overweight → Overweight $215
2025-02-26 main Wells Fargo Overweight → Overweight $205
2025-02-26 reit Needham Hold → Hold —
2025-01-22 reit Needham Hold → Hold —
2025-01-16 reit Needham Hold → Hold —
2024-12-27 main Raymond James Outperform → Outperform $194
News
RSS: Latest MASI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-11 SZYMAN CATHERINE M Chief Executive Officer — 2,101 — —
2026-03-11 YOUNG MICAH W Chief Financial Officer — 873 — —
2026-02-27 YOUNG MICAH W Chief Financial Officer — 15,000 $0.00 $0
2026-02-27 YOUNG MICAH W Chief Financial Officer — 15,000 $175.35 $2,630,250
2026-02-26 YOUNG MICAH W Chief Financial Officer — 2,034 $0.00 $0
2026-02-12 SZYMAN CATHERINE M Chief Executive Officer — 11,141 $132.96 $1,481,307
2026-01-28 SAMPATH ANAND Officer — 18,680 $136.56 $2,555,570
2026-01-28 SAMPATH ANAND Officer — 30,000 $37.84 $1,135,200
2025-11-13 AHMED OMAR Chief Technology Officer — 2,474 $152.43 $377,112
2025-09-23 TRIPODI BLAIR Officer — 15,000 $142.13 $2,131,950
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,526.90
+9.44%
1,395.20
+9.38%
1,275.50
-37.35%
2,035.80
Operating Revenue
1,526.90
+9.44%
1,395.20
+9.38%
1,275.50
-37.35%
2,035.80
Cost Of Revenue
581.70
-3.20%
600.90
+17.85%
509.90
-47.81%
977.00
Reconciled Cost Of Revenue
581.70
-3.20%
600.90
+17.85%
509.90
-47.81%
977.00
Gross Profit
945.20
+19.00%
794.30
+3.75%
765.60
-27.69%
1,058.80
Operating Expense
632.40
-13.46%
730.80
+25.61%
581.80
-31.46%
848.80
Research And Development
126.40
-30.63%
182.20
+39.62%
130.50
-31.82%
191.40
Selling General And Administration
506.00
-7.77%
548.60
+21.56%
451.30
-31.35%
657.40
Total Expenses
1,214.10
-8.83%
1,331.70
+21.98%
1,091.70
-40.21%
1,825.80
Operating Income
312.80
+392.60%
63.50
-65.45%
183.80
-12.48%
210.00
Total Operating Income As Reported
310.00
+392.06%
63.00
-62.05%
166.00
-20.95%
210.00
EBITDA
344.60
+209.06%
111.50
-43.97%
199.00
-43.98%
355.20
Normalized EBITDA
355.00
+204.98%
116.40
-48.40%
225.60
-35.15%
347.90
Reconciled Depreciation
38.80
-20.00%
48.50
+24.68%
38.90
-71.42%
136.10
EBIT
305.80
+385.40%
63.00
-60.65%
160.10
-26.93%
219.10
Total Unusual Items
-10.40
-112.24%
-4.90
+81.58%
-26.60
-464.38%
7.30
Total Unusual Items Excluding Goodwill
-10.40
-112.24%
-4.90
+81.58%
-26.60
-464.38%
7.30
Special Income Charges
-2.80
-460.00%
-0.50
+97.19%
-17.80
0.00
Other Special Charges
2.80
+460.00%
0.50
-97.19%
17.80
—
Impairment Of Capital Assets
—
304.00
+2940.00%
10.00
0.00
Net Income
-151.50
+50.31%
-304.90
-474.11%
81.50
-43.21%
143.50
Pretax Income
272.60
+1150.46%
21.80
-80.71%
113.00
-41.57%
193.40
Net Non Operating Interest Income Expense
-29.80
+19.02%
-36.80
+16.74%
-44.20
-84.94%
-23.90
Interest Expense Non Operating
33.20
-19.42%
41.20
-12.53%
47.10
+83.27%
25.70
Net Interest Income
-29.80
+19.02%
-36.80
+16.74%
-44.20
-84.94%
-23.90
Interest Expense
33.20
-19.42%
41.20
-12.53%
47.10
+83.27%
25.70
Interest Income Non Operating
3.40
-22.73%
4.40
+51.72%
2.90
+61.11%
1.80
Interest Income
3.40
-22.73%
4.40
+51.72%
2.90
+61.11%
1.80
Other Income Expense
-10.40
-112.24%
-4.90
+81.58%
-26.60
-464.38%
7.30
Other Non Operating Income Expenses
—
—
—
—
Gain On Sale Of Security
-7.60
-72.73%
-4.40
+50.00%
-8.80
-220.55%
7.30
Tax Provision
64.90
+1058.93%
5.60
+5.66%
5.30
-89.38%
49.90
Tax Rate For Calcs
0.00
-7.39%
0.00
+446.81%
0.00
-81.78%
0.00
Tax Effect Of Unusual Items
-2.48
-96.55%
-1.26
-0.73%
-1.25
-166.38%
1.88
Net Income Including Noncontrolling Interests
-151.50
+50.31%
-304.90
-474.11%
81.50
-43.21%
143.50
Net Income From Continuing Operation Net Minority Interest
207.70
+1182.10%
16.20
-84.96%
107.70
-24.95%
143.50
Net Income From Continuing And Discontinued Operation
-151.50
+50.31%
-304.90
-474.11%
81.50
-43.21%
143.50
Net Income Continuous Operations
207.70
+1182.10%
16.20
-84.96%
107.70
-24.95%
143.50
Net Income Discontinuous Operations
-359.20
-11.87%
-321.10
-1125.57%
-26.20
—
Normalized Income
215.62
+986.78%
19.84
-85.09%
133.05
-3.65%
138.08
Net Income Common Stockholders
-151.50
+50.31%
-304.90
-474.11%
81.50
-43.21%
143.50
Diluted EPS
-2.83
+50.52%
-5.72
-478.81%
1.51
-41.92%
2.60
Basic EPS
-2.83
+50.52%
-5.72
-471.43%
1.54
-42.54%
2.68
Basic Average Shares
53.60
+0.56%
53.30
+0.95%
52.80
-1.49%
53.60
Diluted Average Shares
54.20
+1.69%
53.30
-1.48%
54.10
-1.99%
55.20
Diluted NI Availto Com Stockholders
-151.50
+50.31%
-304.90
-474.11%
81.50
-43.21%
143.50
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,698.90
-35.30%
2,625.70
-13.67%
3,041.50
-5.27%
3,210.60
Current Assets
926.00
-24.46%
1,225.80
-0.50%
1,231.90
-5.86%
1,308.60
Cash Cash Equivalents And Short Term Investments
152.30
+23.22%
123.60
-24.17%
163.00
-19.66%
202.90
Cash And Cash Equivalents
152.30
+23.22%
123.60
-24.17%
163.00
-19.66%
202.90
Receivables
327.50
-3.59%
339.70
-19.31%
421.00
-16.65%
505.10
Accounts Receivable
260.90
-2.98%
268.90
-22.77%
348.20
-21.91%
445.90
Gross Accounts Receivable
265.40
-2.57%
272.40
-22.83%
353.00
-22.18%
453.60
Allowance For Doubtful Accounts Receivable
-4.50
-28.57%
-3.50
+27.08%
-4.80
+37.66%
-7.70
Other Receivables
30.80
-18.95%
38.00
+2.98%
36.90
+13.89%
32.40
Taxes Receivable
20.90
+12.97%
18.50
-35.31%
28.60
+6.72%
26.80
Inventory
380.30
+29.00%
294.80
-45.91%
545.00
+8.78%
501.00
Raw Materials
152.80
+1.19%
151.00
-34.26%
229.70
+9.43%
209.90
Work In Process
21.80
+13.54%
19.20
-36.00%
30.00
-1.32%
30.40
Finished Goods
205.70
+65.09%
124.60
-56.33%
285.30
+9.44%
260.70
Prepaid Assets
62.00
+47.97%
41.90
-54.65%
92.40
-1.28%
93.60
Restricted Cash
0.00
-100.00%
2.70
-10.00%
3.00
+25.00%
2.40
Assets Held For Sale Current
1.00
-99.76%
420.80
0.00
—
Other Current Assets
2.90
+26.09%
2.30
-69.33%
7.50
+108.33%
3.60
Total Non Current Assets
772.90
-44.79%
1,399.90
-22.64%
1,809.60
-4.86%
1,902.00
Net PPE
387.70
+5.87%
366.20
-24.26%
483.50
+2.41%
472.10
Gross PPE
703.90
+11.50%
631.30
-15.36%
745.90
+10.73%
673.60
Accumulated Depreciation
-316.20
-19.28%
-265.10
-1.03%
-262.40
-30.22%
-201.50
Properties
0.00
0.00
0.00
0.00
Land And Improvements
47.70
+0.00%
47.70
-27.95%
66.20
+1.69%
65.10
Buildings And Improvements
151.80
+5.78%
143.50
-4.97%
151.00
+0.00%
151.00
Machinery Furniture Equipment
208.40
+3.37%
201.60
-25.22%
269.60
+10.67%
243.60
Construction In Progress
24.50
-15.52%
29.00
-51.01%
59.20
+17.00%
50.60
Other Properties
237.20
+33.03%
178.30
+9.79%
162.40
+23.97%
131.00
Leases
34.30
+9.94%
31.20
-16.80%
37.50
+16.10%
32.30
Goodwill And Other Intangible Assets
153.10
-3.28%
158.30
-85.07%
1,060.00
-9.25%
1,168.00
Goodwill
101.00
+4.45%
96.70
-76.28%
407.70
-8.46%
445.40
Other Intangible Assets
52.10
-15.42%
61.60
-90.56%
652.30
-9.73%
722.60
Investments And Advances
5.90
-31.40%
8.60
-13.13%
9.90
-28.26%
13.80
Other Investments
5.90
-10.61%
6.60
-8.33%
7.20
-47.83%
13.80
Non Current Accounts Receivable
64.40
-18.38%
78.90
-10.75%
88.40
+7.15%
82.50
Non Current Deferred Assets
141.20
-2.42%
144.70
+10.88%
130.50
+7.58%
121.30
Non Current Deferred Taxes Assets
114.20
-3.55%
118.40
+10.45%
107.20
+4.59%
102.50
Non Current Prepaid Assets
14.30
-1.38%
14.50
-14.71%
17.00
+24.09%
13.70
Other Non Current Assets
5.30
-99.15%
622.50
+6894.38%
8.90
-21.24%
11.30
Total Liabilities Net Minority Interest
977.70
-37.88%
1,573.80
-6.14%
1,676.70
-10.42%
1,871.70
Current Liabilities
371.60
-39.84%
617.70
+9.56%
563.80
-10.51%
630.00
Payables And Accrued Expenses
230.30
-4.83%
242.00
-40.19%
404.60
-12.95%
464.80
Payables
165.90
+0.79%
164.60
-46.19%
305.90
-13.39%
353.20
Accounts Payable
103.00
-20.16%
129.00
-48.71%
251.50
-9.14%
276.80
Current Accrued Expenses
64.40
-16.80%
77.40
-21.58%
98.70
-11.56%
111.60
Employee Benefits
—
9.00
-5.26%
9.50
-5.94%
10.10
Pensionand Other Post Retirement Benefit Plans Current
83.70
+6.35%
78.70
+25.72%
62.60
-29.90%
89.30
Total Tax Payable
39.40
+30.03%
30.30
-39.64%
50.20
-30.66%
72.40
Income Tax Payable
16.70
+34.68%
12.40
-22.98%
16.10
-49.84%
32.10
Current Debt And Capital Lease Obligation
14.40
-41.70%
24.70
-52.95%
52.50
+55.33%
33.80
Current Debt
6.30
-58.00%
15.00
-56.27%
34.30
+127.15%
15.10
Other Current Borrowings
6.30
-58.00%
15.00
-56.27%
34.30
+127.15%
15.10
Current Capital Lease Obligation
8.10
-16.49%
9.70
-46.70%
18.20
-2.67%
18.70
Current Deferred Liabilities
38.50
-12.10%
43.80
+17.11%
37.40
+3.89%
36.00
Current Deferred Revenue
38.50
-12.10%
43.80
+17.11%
37.40
+3.89%
36.00
Other Current Liabilities
4.70
-97.94%
228.50
+3310.45%
6.70
+9.84%
6.10
Total Non Current Liabilities Net Minority Interest
606.10
-36.61%
956.10
-14.09%
1,112.90
-10.37%
1,241.70
Liabilities Heldfor Sale Non Current
0.10
-99.94%
170.70
—
—
Long Term Debt And Capital Lease Obligation
544.90
-26.13%
737.60
-19.61%
917.50
-7.79%
995.00
Long Term Debt
518.00
-27.48%
714.30
-18.06%
871.70
-7.42%
941.60
Long Term Capital Lease Obligation
26.90
+15.45%
23.30
-49.13%
45.80
-14.23%
53.40
Non Current Pension And Other Postretirement Benefit Plans
—
9.00
-5.26%
9.50
-5.94%
10.10
Tradeand Other Payables Non Current
30.90
+30.38%
23.70
-40.60%
39.90
+2.57%
38.90
Non Current Deferred Liabilities
23.20
+26.78%
18.30
-86.75%
138.10
-26.78%
188.60
Non Current Deferred Revenue
23.00
+27.07%
18.10
-31.44%
26.40
+5.60%
25.00
Non Current Deferred Taxes Liabilities
0.20
+0.00%
0.20
-99.82%
111.70
-31.72%
163.60
Other Non Current Liabilities
7.00
+20.69%
5.80
-26.58%
7.90
-13.19%
9.10
Stockholders Equity
721.20
-31.44%
1,051.90
-22.93%
1,364.80
+1.93%
1,338.90
Common Stock Equity
721.20
-31.44%
1,051.90
-22.93%
1,364.80
+1.93%
1,338.90
Capital Stock
0.10
+0.00%
0.10
+0.00%
0.10
+0.00%
0.10
Common Stock
0.10
+0.00%
0.10
+0.00%
0.10
+0.00%
0.10
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
74.10
+1.37%
73.10
+1.05%
72.34
+0.47%
72.00
Ordinary Shares Number
52.10
-2.80%
53.60
+1.44%
52.84
+0.65%
52.50
Treasury Shares Number
22.00
+12.82%
19.50
+0.00%
19.50
+0.00%
19.50
Additional Paid In Capital
929.10
+10.83%
838.30
+7.01%
783.40
+0.15%
782.20
Retained Earnings
1,339.40
-10.16%
1,490.90
-16.98%
1,795.80
+4.75%
1,714.30
Gains Losses Not Affecting Retained Earnings
-12.50
+88.45%
-108.20
-138.85%
-45.30
-493.91%
11.50
Treasury Stock
1,534.90
+31.28%
1,169.20
+0.00%
1,169.20
+0.00%
1,169.20
Other Equity Adjustments
-12.50
+88.45%
-108.20
-138.85%
-45.30
-493.91%
11.50
Total Equity Gross Minority Interest
721.20
-31.44%
1,051.90
-22.93%
1,364.80
+1.93%
1,338.90
Total Capitalization
1,239.20
-29.84%
1,766.20
-21.03%
2,236.50
-1.93%
2,280.50
Working Capital
554.40
-8.83%
608.10
-8.98%
668.10
-1.55%
678.60
Invested Capital
1,245.50
-30.08%
1,781.20
-21.56%
2,270.80
-1.08%
2,295.60
Total Debt
559.30
-26.63%
762.30
-21.41%
970.00
-5.72%
1,028.80
Net Debt
372.00
-38.58%
605.70
-18.48%
743.00
-1.43%
753.80
Capital Lease Obligations
35.00
+6.06%
33.00
-48.44%
64.00
-11.23%
72.10
Net Tangible Assets
568.10
-36.43%
893.60
+193.18%
304.80
+78.35%
170.90
Tangible Book Value
568.10
-36.43%
893.60
+193.18%
304.80
+78.35%
170.90
Available For Sale Securities
—
2.00
-25.93%
2.70
—
Duefrom Related Parties Current
14.90
+4.20%
14.30
+95.89%
7.30
—
Dueto Related Parties Current
23.50
+343.40%
5.30
+26.19%
4.20
+5.00%
4.00
Financial Assets
1.00
-83.87%
6.20
-45.61%
11.40
-40.93%
19.30
Investmentin Financial Assets
0.00
-100.00%
2.00
-25.93%
2.70
0.00
Notes Receivable
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
217.80
+10.90%
196.40
+108.71%
94.10
+220.07%
29.40
Cash Flow From Continuing Operating Activities
217.20
+33.66%
162.50
+63.15%
99.60
+238.78%
29.40
Cash From Discontinued Operating Activities
0.60
-98.23%
33.90
+716.36%
-5.50
—
Net Income From Continuing Operations
207.70
+1182.10%
16.20
-84.96%
107.70
-24.95%
143.50
Depreciation Amortization Depletion
38.80
-20.00%
48.50
+24.68%
38.90
-71.42%
136.10
Depreciation
—
41.30
-5.92%
43.90
—
Amortization Cash Flow
—
61.70
+13.42%
54.40
—
Depreciation And Amortization
38.80
-20.00%
48.50
+24.68%
38.90
-71.42%
136.10
Amortization Of Intangibles
—
61.70
+13.42%
54.40
—
Other Non Cash Items
3.00
+57.89%
1.90
+0.00%
1.90
+35.71%
1.40
Stock Based Compensation
35.80
-0.83%
36.10
+491.80%
6.10
-87.21%
47.70
Provisionand Write Offof Assets
3.00
+150.00%
1.20
+9.09%
1.10
-15.38%
1.30
Asset Impairment Charge
—
304.00
+2940.00%
10.00
0.00
Deferred Tax
11.80
+150.64%
-23.30
-17.68%
-19.80
+49.62%
-39.30
Deferred Income Tax
11.80
+150.64%
-23.30
-17.68%
-19.80
+49.62%
-39.30
Operating Gains Losses
7.00
-92.77%
96.80
+12000.00%
0.80
+60.00%
0.50
Gain Loss On Sale Of PPE
7.00
-92.77%
96.80
+12000.00%
0.80
+60.00%
0.50
Change In Working Capital
-89.90
-503.36%
-14.90
+59.84%
-37.10
+85.83%
-261.80
Change In Receivables
17.20
+134.68%
-49.60
-182.53%
60.10
+139.72%
-151.30
Changes In Account Receivables
2.20
+103.98%
-55.30
-201.65%
54.40
+137.75%
-144.10
Change In Inventory
-112.10
-398.22%
-22.50
+78.85%
-106.40
+31.75%
-155.90
Change In Payables And Accrued Expense
-18.30
-142.56%
43.00
+318.27%
-19.70
-150.64%
38.90
Change In Accrued Expense
4.90
-87.04%
37.80
+428.70%
-11.50
+54.72%
-25.40
Change In Payable
-23.20
-546.15%
5.20
+163.41%
-8.20
-112.75%
64.30
Change In Account Payable
-27.10
-355.66%
10.60
+226.19%
-8.40
-113.88%
60.50
Change In Other Working Capital
1.20
-91.43%
14.00
+341.38%
-5.80
-139.46%
14.70
Change In Other Current Assets
17.00
+193.10%
5.80
-83.48%
35.10
+385.37%
-12.30
Change In Other Current Liabilities
5.10
+191.07%
-5.60
-1300.00%
-0.40
-109.76%
4.10
Investing Cash Flow
275.10
+637.30%
-51.20
+36.95%
-81.20
+92.32%
-1,057.70
Cash Flow From Continuing Investing Activities
-3.40
+86.35%
-24.90
+60.35%
-62.80
+94.06%
-1,057.70
Cash From Discontinued Investing Activities
278.50
+1158.94%
-26.30
-42.93%
-18.40
—
Net PPE Purchase And Sale
0.20
+102.63%
-7.60
+80.21%
-38.40
+27.27%
-52.80
Purchase Of PPE
-19.40
+8.06%
-21.10
+45.05%
-38.40
+27.27%
-52.80
Sale Of PPE
19.60
+45.19%
13.50
0.00
—
Capital Expenditure
-24.70
+35.51%
-38.30
+38.03%
-61.80
-9.77%
-56.30
Net Investment Purchase And Sale
—
—
—
0.00
Purchase Of Investment
—
—
—
—
Sale Of Investment
—
—
—
0.00
Net Business Purchase And Sale
—
0.00
-100.00%
7.50
+100.75%
-999.70
Purchase Of Business
—
0.00
—
-999.70
Net Intangibles Purchase And Sale
-5.30
+69.19%
-17.20
+26.50%
-23.40
-568.57%
-3.50
Purchase Of Intangibles
-5.30
+69.19%
-17.20
+26.50%
-23.40
—
Net Other Investing Changes
1.70
+1800.00%
-0.10
+90.00%
-1.00
+41.18%
-1.70
Financing Cash Flow
-520.70
-314.57%
-125.60
-119.96%
-57.10
-110.97%
520.40
Cash Flow From Continuing Financing Activities
-518.10
-288.38%
-133.40
-87.89%
-71.00
-113.64%
520.40
Net Issuance Payments Of Debt
-204.10
-39.03%
-146.80
-125.50%
-65.10
-106.86%
948.50
Issuance Of Debt
1,077.40
+1110.56%
89.00
-48.64%
173.30
-84.01%
1,083.90
Repayment Of Debt
-1,281.50
-443.47%
-235.80
+1.09%
-238.40
-76.07%
-135.40
Long Term Debt Issuance
—
—
189.00
—
Long Term Debt Payments
—
—
-240.20
—
Net Long Term Debt Issuance
—
—
-51.20
—
Short Term Debt Issuance
1,077.40
+1110.56%
89.00
-48.64%
173.30
-84.01%
1,083.90
Short Term Debt Payments
-1,281.50
-443.47%
-235.80
+1.09%
-238.40
-76.07%
-135.40
Net Short Term Debt Issuance
-204.10
-39.03%
-146.80
-125.50%
-65.10
-106.86%
948.50
Net Common Stock Issuance
-292.30
-1259.92%
25.20
+260.00%
7.00
+101.78%
-393.40
Common Stock Payments
-363.70
0.00
0.00
+100.00%
-401.50
Repurchase Of Capital Stock
-363.70
0.00
0.00
+100.00%
-401.50
Net Other Financing Charges
-21.70
-83.90%
-11.80
+8.53%
-12.90
+62.82%
-34.70
Changes In Cash
-27.80
-241.84%
19.60
+144.34%
-44.20
+91.30%
-507.90
Effect Of Exchange Rate Changes
-0.30
+95.31%
-6.40
-328.57%
2.80
+109.06%
-30.90
Beginning Cash Position
181.40
+7.85%
168.20
-19.75%
209.60
-71.99%
748.40
End Cash Position
153.30
-15.49%
181.40
+7.85%
168.20
-19.75%
209.60
Free Cash Flow
193.10
+22.14%
158.10
+389.47%
32.30
+220.07%
-26.90
Interest Paid Supplemental Data
—
39.10
-23.33%
51.00
+121.74%
23.00
Income Tax Paid Supplemental Data
—
41.90
-22.98%
54.40
-37.69%
87.30
Change In Income Tax Payable
3.90
+172.22%
-5.40
-2800.00%
0.20
-94.74%
3.80
Change In Tax Payable
3.90
+172.22%
-5.40
-2800.00%
0.20
-94.74%
3.80
Common Stock Issuance
71.40
+183.33%
25.20
+260.00%
7.00
-13.58%
8.10
Issuance Of Capital Stock
71.40
+183.33%
25.20
+260.00%
7.00
-13.58%
8.10
Sale Of Business
—
—
7.50
—
Cash From Discontinued Financing Activities
-2.60
-133.33%
7.80
-43.88%
13.90
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category